Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells.


Journal

Nature protocols
ISSN: 1750-2799
Titre abrégé: Nat Protoc
Pays: England
ID NLM: 101284307

Informations de publication

Date de publication:
12 2019
Historique:
received: 12 01 2019
accepted: 27 06 2019
pubmed: 17 11 2019
medline: 8 2 2020
entrez: 17 11 2019
Statut: ppublish

Résumé

Alveolar epithelial type II cells (AEC2s) are the facultative progenitors of lung alveoli and serve as the surfactant-producing cells of air-breathing organisms. Although primary human AEC2s are difficult to maintain stably in cell cultures, recent advances have facilitated the derivation of AEC2-like cells from human pluripotent stem cells (hPSCs) in vitro. Here, we provide a detailed protocol for the directed differentiation of hPSCs into self-renewing AEC2-like cells that can be maintained for up to 1 year in culture as epithelial-only spheres without the need for supporting mesenchymal feeder cells. The month-long protocol requires recapitulation of the sequence of milestones associated with in vivo development of the distal lung, beginning with differentiation of cells into anterior foregut endoderm, which is followed by their lineage specification into NKX2-1

Identifiants

pubmed: 31732721
doi: 10.1038/s41596-019-0220-0
pii: 10.1038/s41596-019-0220-0
pmc: PMC7275645
mid: NIHMS1584457
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3303-3332

Subventions

Organisme : NCATS NIH HHS
ID : U01 TR001810
Pays : United States
Organisme : NHLBI NIH HHS
ID : R24 HL123828
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL134745
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095993
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL134766
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL148692
Pays : United States

Références

Mason, R. J. & Williams, M. C. Type II alveolar cell. Defender of the alveolus. Am. Rev. Respir. Dis. 115, 81–91 (1977).
pubmed: 326115
Whitsett, J. A., Wert, S. E. & Weaver, T. E. Diseases of pulmonary surfactant homeostasis. Annu. Rev. Pathol. 10, 371–393 (2015).
doi: 10.1146/annurev-pathol-012513-104644
Jacob, A. et al. Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells. Cell Stem Cell 21, 472–488.e10 (2017).
doi: 10.1016/j.stem.2017.08.014
Serra, M. et al. Pluripotent stem cell differentiation reveals distinct developmental pathways regulating lung- versus thyroid-lineage specification. Development 144, 3879–3893 (2017).
doi: 10.1242/dev.150193
Green, M. D. et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat. Biotechnol. 29, 267–272 (2011).
doi: 10.1038/nbt.1788
Huang, S. X. L. et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat. Biotechnol. 32, 84–91 (2014).
doi: 10.1038/nbt.2754
Longmire, T. A. et al. Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. Cell Stem Cell 10, 398–411 (2012).
doi: 10.1016/j.stem.2012.01.019
Hawkins, F. et al. Prospective isolation of NKX2-1-expressing human lung progenitors derived from pluripotent stem cells. J. Clin. Invest. 127, 2277–2294 (2017).
doi: 10.1172/JCI89950
Kurmann, A. A. et al. Regeneration of thyroid function by transplantation of differentiated pluripotent stem cells. Cell Stem Cell 17, 527–542 (2015).
doi: 10.1016/j.stem.2015.09.004
Gotoh, S. et al. Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells. Stem Cell Rep. 3, 394–403 (2014).
doi: 10.1016/j.stemcr.2014.07.005
McCauley, K. B., Hawkins, F. & Kotton, D. N. Derivation of epithelial-only airway organoids from human pluripotent stem cells. Curr. Protoc. Stem Cell Biol. 45, e51 (2018).
doi: 10.1002/cpsc.51
McCauley, K. B. et al. Efficient derivation of functional human airway epithelium from pluripotent stem cells via temporal regulation of Wnt signaling. Cell Stem Cell 20, 844–857.e6 (2017).
doi: 10.1016/j.stem.2017.03.001
Yamamoto, Y. et al. Long-term expansion of alveolar stem cells derived from human iPS cells in organoids. Nat. Methods 14, 1097–1106 (2017).
doi: 10.1038/nmeth.4448
McCauley, K. B. et al. Single-cell transcriptomic profiling of pluripotent stem cell-derived SCGB3A2
doi: 10.1016/j.stemcr.2018.03.013
Minoo, P., Su, G., Drum, H., Bringas, P. & Kimura, S. Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(−/−) mouse embryos. Dev. Biol. 209, 60–71 (1999).
doi: 10.1006/dbio.1999.9234
Mucenski, M. L. et al. Beta-catenin regulates differentiation of respiratory epithelial cells in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L971–L979 (2005).
doi: 10.1152/ajplung.00172.2005
Liu, Y. & Hogan, B. L. M. Differential gene expression in the distal tip endoderm of the embryonic mouse lung. Gene Expr. Patterns 2, 229–233 (2002).
doi: 10.1016/S1567-133X(02)00057-1
Gonzales, L. W., Guttentag, S. H., Wade, K. C., Postle, A. D. & Ballard, P. L. Differentiation of human pulmonary type II cells in vitro by glucocorticoid plus cAMP. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L940–L951 (2002).
doi: 10.1152/ajplung.00127.2002
Frank, D. B. et al. Emergence of a wave of Wnt signaling that regulates lung alveologenesis by controlling epithelial self-renewal and differentiation. Cell Rep. 17, 2312–2325 (2016).
doi: 10.1016/j.celrep.2016.11.001
Huang, S. X. L. et al. The in vitro generation of lung and airway progenitor cells from human pluripotent stem cells. Nat. Protoc. 10, 413–425 (2015).
doi: 10.1038/nprot.2015.023
Chen, Y.-W. et al. A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat. Cell Biol. 19, 542–549 (2017).
doi: 10.1038/ncb3510
Dye, B. R. et al. In vitro generation of human pluripotent stem cell derived lung organoids. Elife 4, 1999 (2015).
doi: 10.7554/eLife.05098
Miller, A. J. et al. In vitro induction and in vivo engraftment of lung bud tip progenitor cells derived from human pluripotent stem cells. Stem Cell Rep. 10, 101–119 (2018).
doi: 10.1016/j.stemcr.2017.11.012
Korogi, Y. et al. In vitro disease modeling of Hermansky-Pudlak syndrome type 2 using human induced pluripotent stem cell-derived alveolar organoids. Stem Cell Rep. 12, 431–440 (2019).
doi: 10.1016/j.stemcr.2019.01.014
Zacharias, W. J. et al. Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. Nature 555, 251–255 (2018).
doi: 10.1038/nature25786
Barkauskas, C. E. et al. Type 2 alveolar cells are stem cells in adult lung. J. Clin. Invest. 123, 3025–3036 (2013).
doi: 10.1172/JCI68782
D’Amour, K. A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534–1541 (2005).
doi: 10.1038/nbt1163
Gouon-Evans, V. et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat. Biotechnol. 24, 1402–1411 (2006).
doi: 10.1038/nbt1258
Ogawa, S. et al. Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development 140, 3285–3296 (2013).
doi: 10.1242/dev.090266
Christodoulou, C. et al. Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes. J. Clin. Invest. 121, 2313–2325 (2011).
doi: 10.1172/JCI43853
Loh, K. M. et al. Efficient endoderm induction from human pluripotent stem cells by logically directing signals controlling lineage bifurcations. Cell Stem Cell 14, 237–252 (2014).
doi: 10.1016/j.stem.2013.12.007

Auteurs

Anjali Jacob (A)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA.
The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Marall Vedaie (M)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA.
The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

David A Roberts (DA)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA.
The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Dylan C Thomas (DC)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA.
The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Carlos Villacorta-Martin (C)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA.

Konstantinos-Dionysios Alysandratos (KD)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA.
The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Finn Hawkins (F)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA.
The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Darrell N Kotton (DN)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA. dkotton@bu.edu.
The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA, USA. dkotton@bu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH